Allies in the Race Against Time: Navigating Alzheimer's Disease with Early Detection, Therapeutic Innovations, and Patient-Centric Care " Module Three

Target Audience
This activity is designed to meet the educational needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants

Program Overview
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in disease-modifying therapies have brought hope for slowing or preventing disease progression and improving patient outcomes. However, timely diagnosis and early intervention are crucial for maximizing the likelihood of successful treatment. Clinicians, families, and researchers need to be aware of the importance of early recognition and diagnosis of AD, as well as the latest evidence on biomarkers that aid in early diagnosis. Additionally, understanding the mechanisms of action, efficacy, and safety data for new and emerging disease-modifying therapies is essential.

Learning Objectives
Upon completion of this activity, participants should be able to:

Evaluate the mechanisms of action, efficacy, and safety data for disease-modifying therapies newly approved and currently in development for AD, to make informed decisions regarding patient treatment options